Answer:
1.$79,200,000
2.No entry is made on the grant date
3 - 5
Dr Compensation expense 264
Cr Paid-in capital—restricted stock 264
6.
Dr Paid-in capital—restricted stock 792
Cr Common stock 11
Cr Paid-in capital—excess of par (remainder) 781
Explanation:
1.Total compensation cost pertaining to the RSUs
Restricted stock units * Market price
11,000,000 *7.20
=$79,200,000
2.
January 1, 2016
No entry is made on the grant date
3 - 5
December 31, 2016, 2017 and 2018. (Note: The entry is the same for years 2016 - 2018.)
Dr Compensation expense 264
($792 million ÷ 3 years)
Cr Paid-in capital—restricted stock 264
6.
Dr Paid-in capital—restricted stock 792
Cr Common stock 11
(11 million shares x $1 par)
Cr Paid-in capital—excess of par (remainder) 781